News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Solventum Corp. (SOLV) stock increased by 2.46% to $88.59 on Friday, marking its third consecutive day of gains. This rise occurred during a generally negative trading session where the S&P 500 Index (SPX) fell 0.17% and the Dow Jones Industrial Average (DJIA) fell 0.20%, …
Solventum SOLV plans to separate its Health Information Systems (HIS) business as part of its portfolio optimization strategy. The move is expected to sharpen the company's focus on its core MedSurg and Dental Solutions businesses while allowing HIS to pursue its growth opportunities as …
Sharemaestro market context Price above Trend Line 52 weeks +2.4% · Next-week setup negative 8.9%Solventum (SOLV) recently announced slightly higher Q2 2026 results and confirmed that activist investor Trian Fund Management influenced its US$4.10 billion asset sale and plans to separate its Health Information Systems business. Management reiterated a focus on disciplined "tuck-in" acquisitions and a growing deal …
Solventum Corp. (SOLV) stock rose 1.41% to $85.29 on Wednesday, outperforming a mixed market session where the S&P 500 gained 0.26% and the Dow Jones Industrial Average fell 0.04%. The company's stock closed 5.23% below its 52-week high of $90.00.
Sharemaestro market context Price above Trend Line 52 weeks +2.4% · Next-week setup negative 8.9%American Securities-affiliated investment vehicles have reported a significant beneficial ownership stake in SOLV Energy, Inc. (NASDAQ: MWH), controlling 79.4% of its Class A common stock on an as-exchanged basis. This disclosure comes from a Schedule 13G/A filing, indicating shared voting and dispositive power over …
Solventum Corp. (SOLV) shares dropped 1.30% to $84.10 on Tuesday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also saw declines. This fall ended a two-day winning streak for the stock.
Sharemaestro market context Price above Trend Line 52 weeks +2.4% · Next-week setup negative 8.9%SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 2.2% year on year to $2.21 billion. Its non-GAAP profit of $2.55 per share was …
Sharemaestro market context Price above Trend Line 52 weeks +2.4% · Next-week setup negative 8.9%Solventum is strategically focusing on the Medtech sector and plans to separate its Healthcare Information Systems (HIS) segment. The company, recently spun out, is undergoing a significant restructuring, including the sale of its purification and filtration business to reduce leverage and improve margins. This …
This article provides an analyst report on Solventum Corporation (SOLV), a healthcare firm spun out from 3M in spring 2024. The report highlights strong growth in Solventum's medical-surgical segment, which now contributes approximately 64% of its revenue, following the sale of its purification and …
The financial troubles of Thames Water, including a large signing-on fee for its finance chief amid £20 billion of debt, have highlighted the risks in essential infrastructure. This article examines three stocks—SSE (LSE:SSE), Galliford Try Holdings (LSE:GFRD), and SOLV Energy (MWH)—that are exposed to …
112,273,571 Class A Common Stock of SOLV Energy, Inc. are subject to a lock-up agreement that ends on August 10, 2026. This lock-up period, starting from February 10, 2026, prevents directors, executive officers, and certain common stock holders from disposing of or hedging their …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Solventum's analyst fair value estimate has been revised from US$82.15 to US$93.15, a shift of about 13% in the updated framework. This adjustment …
Sharemaestro market context Price above Trend Line 52 weeks +2.4% · Next-week setup negative 8.9%Solventum Corporation (NYSE:SOLV) has received a consensus "Hold" rating from thirteen brokerages, with an average 12-month price target of $91.64, surpassing its opening price of $83.00. The company's Q2 results exceeded expectations, reporting adjusted EPS of $2.55 against a $1.91 consensus and revenue of …
Solventum Corp (NYSE: SOLV) stock reached a 52-week high of $89.35, trading near its peak with a market capitalization of $15.15 billion and an attractive P/E ratio of 9.3. The company has seen a 21.57% increase in stock value over the past year, reflecting …
Solventum (NYSE: SOLV) announced its intent to separate its Health Information Systems business to optimize its portfolio and strengthen its focus as a dedicated MedTech company. This strategic move aims to unlock shareholder value, accelerate innovation, and allow both entities to pursue distinct growth …
Search by ticker symbol or company name and select a result to open its chart.